People across the UK who use the FreeStyle Libre 3 or FreeStyle Libre 3 Plus sensors have been warned that some sensors are giving incorrect readings showing low glucose levels, which if undetected ...

A report by the Association of Medical Research Charities (AMRC) and Wellcome calculates the economic impact of our flagship DiRECT trial into type 2 diabetes remission, showing the potential for huge ...

The Driving and Vehicle Licensing Agency (DVLA) will now allow people with diabetes who hold Group 2 licences to use continuous glucose monitoring to monitor their blood glucose levels when driving.

Our researchers have shown that a pioneering gene therapy can reduce early signs of kidney damage in mice with diabetes, paving the way to a new treatment to protect against one of the most serious ...

The drug manufacturer Novo Nordisk has announced it will withdraw Levemir insulin in all forms by the end of 2026. Here, we look at what this means for people with diabetes who are affected, and what ...

The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...

We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.

Our research has provided the most detailed picture yet of how weight loss improves health. The findings offer important clues about how losing weight can help people with type 2 diabetes improve ...

We take a look at some of the exciting diabetes research developments announced in May, and what the findings could mean for people living with or affected by diabetes.

Our new research shows that 97% of people from South Asian, Black African and Black Caribbean communities in the UK have experienced some kind of diabetes-related stigma.

We’ve worked with Breakthrough T1D (formally JDRF) and Kidney Research UK to find the most urgent research gaps which need filling to protect the kidney health of people living diabetes.

New research we funded has shown that a reduced calorie diet in late pregnancy is safe and beneficial for women with gestational diabetes who are living with overweight or obesity.